KMT2C/D COMPASS complex-associated diseases [K CD COM-ADs]: an emerging class of congenital regulopathies | Clinical Epigenetics | Full Text

KMT2C/D COMPASS complex-associated diseases [K CD COM-ADs]: an emerging class of congenital regulopathies | Clinical Epigenetics | Full Text

KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies

The type 2 lysine methyltransferases KMT2C and KMT2D are large, enzymatically active scaffold proteins that form the core of nuclear regulatory structures known as KMT2C/D COMPASS complexes (complex of protein...

Authors:William J. Lavery, Artem Barski, Susan Wiley, Elizabeth K. Schorry and Andrew W. Lindsley

Citation:Clinical Epigenetics 2020 12:10

Content type:Review

Published on: 10 January 2020

• ViewFull Text
 
• ViewPDF